Archives by Month:

Archives by Year:

Stocks Going Ex Dividend The Third Week Of November 2017

Stocks Going Ex Dividend The Third Week Of November 2017

Here is our latest update on the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only […]
Market Talk – Saturday, Nov. 11

Market Talk – Saturday, Nov. 11

Asian cash responded to the US news of possible tax plan delays and we saw profit-taking and nerves for the first time in a while. It’s interesting that this has occurred on our expected November temporary pause. The Nikkei has returned -0.8%, which added to yesterday’s decline but is falling from the 26 year high. […]
Bonds Rocked And Expected Moves Hold Markets Together

Bonds Rocked And Expected Moves Hold Markets Together

The indices saw selling right to the edge of their expected moves for the week and closed the week inside the expected move. Watch this crucial video so you understand how the move in bonds will impact the overall market next week.
E
                                                
                        VIX On Buy Signal While SPX Consolidates

E VIX On Buy Signal While SPX Consolidates

VIX rose from its Master Cycle low to close above Long-term support/resistance at 11.11.  VIX is now on a buy signal. The inverted Head & Shoulders formation now has a completed right shoulder giving a potential target for the next move higher.   (Bloomberg)  Volatility roared back into the U.S. equity market as fresh concern […]
USAA Launches Intermediate-Term Total Bond Market ETF

USAA Launches Intermediate-Term Total Bond Market ETF

USAA launched a new fixed-income fund focused on providing exposure to the aggregate bond market. USAA Core Intermediate-Term Bond ETF UITB tracks the Bloomberg Barclays US Aggregate Bond Index and holds a portfolio of bonds that primarily target the intermediate end of the yield curve. Fund Characteristics The fund’s index seeks to measure the performance of intermediate […]
Secular Bull Market – Keep An Open Mind

Secular Bull Market – Keep An Open Mind

Economic Data And Forecasts For The Weeks Of November 13 And November 20

Economic Data And Forecasts For The Weeks Of November 13 And November 20

Here are my forecasts for upcoming economic data.         Forecast Prior Observation Consensus   Week of November 13         November 13         Treasury Budget – October -$60.0B 8.0 -58.1             November 14         Producer Price Index – October […]
US Dollar: Yellen, Key Data May Boost Politics-Driven Volatility

US Dollar: Yellen, Key Data May Boost Politics-Driven Volatility

Fundamental Forecast for the US Dollar: Neutral US Dollar down as Senate tax cut proposal underwhelms markets Politics likely still in focus as markets weigh impact 2018 Fed path Yellen speech, CPI and retail sales data amplify risk of volatility Politics dominated US Dollar price action last week, as expected. Senate Republicans underwhelmed with their version of tax […]
This, That & The Other Thing

This, That & The Other Thing

  Last week, I was unable to produce a newsletter so I will be updating my analysis from two weeks ago. Fortunately, nothing has changed much as the ongoing levitation of asset prices in hopes of “tax cuts/reform” still linger even as the risk of disappointment seems to have risen. On Thursday and Friday, the market experienced […]
Week In Review: China’s Creat To Restructure $1.5 Billion Biotest Takeover

Week In Review: China’s Creat To Restructure $1.5 Billion Biotest Takeover

Creat Group of China has withdrawn its current $1.5 billion offer to acquire Biotest, a German blood plasma products corporation, because US regulators refused to approve the deal (see story). According to Bloomberg, the Committee on Foreign Investment in the United States was worried that a China corporation would have access to US donor information. Creat and Biotest said the acquisition can not be […]